Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor ComR is a cytoplasmic receptor and DNA-binding protein primarily found in the genus Streptococcus [1]. It serves as the master regulator of the ComRS quorum-sensing system, which controls the state of natural competence in these bacteria [2]. The protein is activated upon binding its cognate signaling pheromone, XIP (sigX-inducing peptide), which is imported into the cell after being processed from the ComS precursor [3]. Once activated, the ComR-XIP complex binds to specific promoter regions to induce the expression of the alternative sigma factor SigX [1]. SigX then coordinates the transcription of late competence genes required for the assembly of the transformasome, the machinery used for DNA uptake and integration [2]. This biological process is critical for horizontal gene transfer, enabling the rapid acquisition of antibiotic resistance genes and virulence factors [1]. Because it facilitates bacterial adaptation and the spread of resistance, ComR is considered a promising target for anti-virulence drug development [4]. Inhibiting ComR could potentially disarm pathogens by preventing them from evolving resistance or forming robust biofilms [2]. While no drugs are currently approved, research is focused on synthetic peptide analogs and small molecules that can disrupt the ComR-XIP interaction [4].
Activation of the ComRS quorum-sensing pathway by binding the XIP pheromone, leading to the induction of SigX-mediated competence genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor ComR (ComR).